Nottingham Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Nottingham Advisors's AMGN Position: Q2 2023 in Review
Nottingham Advisors sold out of Amgen (AMGN) in Q2 2023, closing a stake of 920 shares — an estimated $222K sold.
Nottingham Advisors first reported a position in AMGN in Q3 2016 and held it in 24 quarters. The position peaked at $323K in Q3 2017. 2,390 funds tracked by Wall St. Rank hold AMGN as of Q2 2023.
- Nottingham Advisors reported no remaining Amgen position as of Q2 2023 after selling out during the quarter.
- Nottingham Advisors sold 920 Amgen shares in Q2 2023, an estimated $222K.
- Nottingham Advisors first reported a position in Amgen in Q3 2016 and held it in 24 quarters.
- Nottingham Advisors's Amgen position peaked at $323K in Q3 2017.
- 2,390 funds tracked by Wall St. Rank held Amgen as of Q2 2023.
Based on Nottingham Advisors's 13F filing for Q2 2023, filed 8 Aug 2023.